SIMONOVIĆ BABIĆ, Jasmina et al. Real-life data on the efficacy and safety of ombitasvir/paritaprevir/ /ritonavir + dasabuvir + ribavirin in the patients with genotype 1 chronic hepatitis C virus infection in Serbia. Vojnosanitetski pregled, [S. l.], v. 76, n. 5, 2021. DOI: 10.2298/VSP170727186S. Dostupno na: https://asistent.ceon.rs/index.php/vsp/article/view/14677. Pristupljeno: 12 jul. 2026.